Evidence map›Paper›PMID 11884453›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2002

Two new isotype-specific switching activities detected for Ig class switching.

Limei Ma, Henry H Wortis, Amy L Kenter

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2011
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Limei MaDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL 60612,USA.
Henry H Wortis
Amy L Kenter
University of Illinois Urbana-Champaign · USTufts University · US

Funding

Factors and DNA Motifs Involved in Ig Class SwitchR01AI052400 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KENTER, AMY L · 2003 to 2012
$3.7M
CHARACTERIZING ISOTYPE SWITCHING USING SWITCH SUBSTRATESR01AI045045 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KENTER, AMY L. · 2000 to 2003
$1.1M
LYMPHOCYTE DEVELOPMENTR01AI015803 · NIAID · TUFTS UNIVERSITY BOSTON · PI WORTIS, HENRY H · 1985 to 2002
$805k
Class switch recombination during early B cell developmentR21AI106328 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KENTER, AMY L · 2013 to 2014
$424k
B CELL FUNCTION IN LUPUS PRONE MICER01AR043773 · NIAMS · TUFTS UNIVERSITY BOSTON · PI WORTIS, HENRY H · 1996 to 2000
$275k
LYMPHOCYTE DEVELOPMENTR37AI015803 · NIAID · TUFTS UNIVERSITY BOSTON · PI WORTIS, HENRY H · 1987 to 1991
–
NIAID NIH HHS AI15803NIAID NIH HHS AI 45045NIAID NIH HHS R01 AI045045NIAID NIH HHS R01 AI052400NIAID NIH HHS R21 AI106328NIAMS NIH HHS AR43773
6 · The paper itself

Abstract

Ig class switch recombination (CSR) occurs by an intrachromosomal deletional process between switch (S) regions in B cells. To facilitate the study of CSR, we derived a new B cell line, 1.B4.B6, which is uniquely capable of mu --> gamma3, mu --> epsilon, and mu --> alpha, but not mu --> gamma1 CSR at its endogenous loci. The 1.B4.B6 cell line was used in combination with plasmid-based isotype-specific S substrates in transient transfection assays to test for the presence of trans-acting switching activities. The 1.B4.B6 cell line supports mu --> gamma3, but not mu --> gamma1 recombination, on S substrates. In contrast, normal splenic B cells activated with LPS and IL-4 are capable of plasmid-based mu --> gamma1 CSR and demonstrate that this S plasmid is active. Activation-induced deaminase (AID) was used as a marker to identify existing B cell lines as possible candidates for supporting CSR. The M12 and A20 cell lines were identified as AID positive and, following activation with CD40L and other activators, were found to differentially support mu --> epsilon and mu --> alpha plasmid-based CSR. These studies provide evidence for two new switching activities for mu --> gamma1 and mu --> epsilon CSR, which are distinct from mu --> gamma3 and mu --> alpha switching activities previously described. AID is expressed in all the B cell lines capable of CSR, but cannot account for the isotype specificity defined by the S plasmid assay. These results are consistent with a model in which isotype-specific switching factors are either isotype-specific recombinases or DNA binding proteins with sequence specificity for S DNA.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsBase SequenceB-LymphocytesCell Line, TransformedCell Transformation, ViralClone CellsCoculture TechniquesCytidine DeaminaseImmunoglobulin alpha-ChainsImmunoglobulin Class SwitchingImmunoglobulin epsilon-ChainsImmunoglobulin gamma-ChainsImmunoglobulin IsotypesImmunoglobulin mu-ChainsLymphocyte ActivationAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseImmunoglobulin alpha-ChainsImmunoglobulin epsilon-ChainsImmunoglobulin gamma-ChainsImmunoglobulin IsotypesImmunoglobulin mu-Chains

Identifiers

PMID11884453
PMCPMC4801030
OpenAlexW1580273679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.